Lupin partners with ERN to launch Luforbec® in Spain
Lupin partners with ERN to launch Luforbec® in Spain. Lupin Limited has announced a collaboration with ERN to launch Luforbec® (beclometasone/formoterol) pMDI in Spain. The product is indicated for asthma and COPD management. This marks Lupin’s strategic expansion into the European respiratory market.
📊 STOCKS: LUPIN | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Pharma
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.